04:29 PM EST, 03/08/2024 (MT Newswires) -- Jacob Chacko, Director, President and CEO, on March 06, 2024, sold 40,000 shares in Oric Pharmaceuticals ( ORIC ) for $648,380. Following the Form 4 filing with the SEC, Chacko has control over a total of 728,544 shares of the company, with 728,544 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1796280/000141588924007345/xslF345X03/form4-03082024_090337.xml
Price: 15.1, Change: +0.11, Percent Change: +0.73